Basic Information

Gene symbol ERBB2 Synonyms CD340, HER-2, HER-2/neu, HER2, MLN 19, MLN-19, NEU, NGL, TKR1, VSCN2, c-ERB-2, c-ERB2, p185(erbB2) Type of gene protein-coding
Gene perturbation-related omics dataset PerturbAtlas | PertOrg
Description erb-b2 receptor tyrosine kinase 2

GTO ID GTC1318
Trial ID NCT00902044
Disease Sarcoma
Altered gene HER2
Therapeutic/Target gene Target gene
TherapyCAR-T cell
Treatment HER2 CAR-T cells
Generation2nd
PhasePhase1
Recruitment statusActive, Not Recruiting
TitleHer2 Chimeric Antigen Receptor Expressing T Cells in Advanced Sarcoma
Year2009
CountryUnited States
Company sponsorBaylor College of Medicine
Other ID(s)24489-HEROS|HEROS
Vector information
Vectorretrovirus
ConstructscFv-CD28-CD3ζ
Transgene/Inserted geneHER2-specific murine scFv FRP5; CD28 transmembrane domain; CD28.ζ signaling domain
Vector production methodPeripheral-blood mononuclear cells were activated with immobilized CD3 antibody (Ortho Biotech, Toronto, Ontario, Canada) or immobilized CD3 and CD28 antibodies (P 6, 12, 13, 16, 17, 18; Miltenyi, Cologne, Germany) and recombinant IL-2 (100 U/mL; Proleukin, Chiron, Emeryville, CA) and then transduced on day 3 with retroviral particles encoding an HER2.CD28.ζ-CAR (Appendix, online only) in 24-well plates precoated with Retronectin (FN CH-296; Takara, Shiga, Japan). After transduction, T-cell lines were expanded in the presence of IL-2 (50 to 100 U/mL) added twice weekly until the specified cell dose was achieved.

Clinical Result

Cohort1: dose level 1
Administration route None
Dosage 1E4 cells/m^2
Donor type Autologous
Pts 3
Age Child, Adult, Older_Adult
Lymph depletion No
References PMID: 25800760
Cohort2: dose level 2
Administration route None
Dosage 3E4 cells/m^2
Donor type Autologous
Pts 2
Age Child, Adult, Older_Adult
Lymph depletion No
References PMID: 25800760
Cohort3: dose level 3
Administration route None
Dosage 1E5 cells/m^2
Donor type Autologous
Pts 2
Age Child, Adult, Older_Adult
Lymph depletion No
References PMID: 25800760
Cohort4: dose level 4
Administration route None
Dosage 1E6 cells/m^2
Donor type Autologous
Pts 2
Age Child, Adult, Older_Adult
Lymph depletion No
References PMID: 25800760
Cohort5: dose level 5
Administration route None
Dosage 3E6 cells/m^2
Donor type Autologous
Pts 2
Age Child, Adult, Older_Adult
Lymph depletion No
References PMID: 25800760
Cohort6: dose level 6
Administration route None
Dosage 1E7 cells/m^2
Donor type Autologous
Pts 2
Age Child, Adult, Older_Adult
Lymph depletion No
References PMID: 25800760
Cohort7: dose level 7
Administration route None
Dosage 3E7 cells/m^2
Donor type Autologous
Pts 2
Age Child, Adult, Older_Adult
Lymph depletion No
References PMID: 25800760
Cohort8: dose level 8
Administration route None
Dosage 1E8 cells/m^2
Donor type Autologous
Pts 4
Age Child, Adult, Older_Adult
Lymph depletion No
References PMID: 25800760

Relationship Graph

Overview of Knowledge Graph